Valinor Discovery

Valinor Discovery is a biotechnology company that uses generative machine learning and proprietary patient-matched longitudinal multi-omics datasets to simulate how therapies perform in virtual patients before clinical trials begin. Its platform constructs patient-centric simulations of disease progression and treatment response, providing insights into efficacy, safety signals, patient stratification, and biomarker discovery. The platform initially targets oncology and neurology, enabling biopharmaceutical companies to distinguish responders from non-responders, surface novel biology, and reduce late-stage clinical failure risk. Custom models trained on primary cell and clinical assay data are delivered via a hosted web portal in partnership with Latch Bio.